CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:AFX • DE0005313704
28 EUR
-0.04 (-0.14%)
Last: Jan 30, 2026, 07:00 PM
We assign a fundamental rating of 5 out of 10 to AFX. AFX was compared to 68 industry peers in the Health Care Equipment & Supplies industry. AFX has only an average score on both its financial health and profitability. AFX scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- AFX had positive earnings in the past year.
- AFX had a positive operating cash flow in the past year.
- In the past 5 years AFX has always been profitable.
- In the past 5 years AFX always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of AFX (4.15%) is better than 62.50% of its industry peers.
- With a Return On Equity value of 6.67%, AFX perfoms like the industry average, outperforming 54.69% of the companies in the same industry.
- With a Return On Invested Capital value of 5.79%, AFX perfoms like the industry average, outperforming 54.69% of the companies in the same industry.
- AFX had an Average Return On Invested Capital over the past 3 years of 7.11%. This is below the industry average of 9.62%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.15% | ||
| ROE | 6.67% | ||
| ROIC | 5.79% |
ROA(3y)6.33%
ROA(5y)7.85%
ROE(3y)9.62%
ROE(5y)11.54%
ROIC(3y)7.11%
ROIC(5y)9.66%
1.3 Margins
- AFX's Profit Margin of 6.34% is in line compared to the rest of the industry. AFX outperforms 54.69% of its industry peers.
- In the last couple of years the Profit Margin of AFX has declined.
- AFX has a Operating Margin (10.03%) which is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of AFX has declined.
- The Gross Margin of AFX (52.76%) is comparable to the rest of the industry.
- AFX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.03% | ||
| PM (TTM) | 6.34% | ||
| GM | 52.76% |
OM growth 3Y-21.67%
OM growth 5Y-5.49%
PM growth 3Y-25.69%
PM growth 5Y-7.11%
GM growth 3Y-3.8%
GM growth 5Y-1.12%
2. Health
2.1 Basic Checks
- AFX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, AFX has about the same amount of shares outstanding.
- AFX has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AFX has an improved debt to assets ratio.
2.2 Solvency
- AFX has an Altman-Z score of 2.95. This is not the best score and indicates that AFX is in the grey zone with still only limited risk for bankruptcy at the moment.
- AFX has a Altman-Z score of 2.95. This is in the better half of the industry: AFX outperforms 60.94% of its industry peers.
- AFX has a debt to FCF ratio of 4.41. This is a neutral value as AFX would need 4.41 years to pay back of all of its debts.
- AFX has a Debt to FCF ratio of 4.41. This is comparable to the rest of the industry: AFX outperforms 57.81% of its industry peers.
- A Debt/Equity ratio of 0.27 indicates that AFX is not too dependend on debt financing.
- AFX's Debt to Equity ratio of 0.27 is fine compared to the rest of the industry. AFX outperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 4.41 | ||
| Altman-Z | 2.95 |
ROIC/WACC0.85
WACC6.83%
2.3 Liquidity
- A Current Ratio of 2.35 indicates that AFX has no problem at all paying its short term obligations.
- The Current ratio of AFX (2.35) is better than 70.31% of its industry peers.
- A Quick Ratio of 1.44 indicates that AFX should not have too much problems paying its short term obligations.
- AFX has a better Quick ratio (1.44) than 73.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
- AFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.90%.
- The Earnings Per Share has been growing slightly by 3.28% on average over the past years.
- AFX shows a small growth in Revenue. In the last year, the Revenue has grown by 7.82%.
- Measured over the past years, AFX shows a quite strong growth in Revenue. The Revenue has been growing by 10.78% on average per year.
EPS 1Y (TTM)-19.9%
EPS 3Y-21.2%
EPS 5Y3.28%
EPS Q2Q%-14.49%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y5.39%
Revenue growth 5Y10.78%
Sales Q2Q%8.27%
3.2 Future
- AFX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.64% yearly.
- The Revenue is expected to grow by 6.21% on average over the next years.
EPS Next Y20.35%
EPS Next 2Y21.07%
EPS Next 3Y21.31%
EPS Next 5Y19.64%
Revenue Next Year4.23%
Revenue Next 2Y5.18%
Revenue Next 3Y5.72%
Revenue Next 5Y6.21%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- AFX is valuated rather expensively with a Price/Earnings ratio of 17.39.
- Based on the Price/Earnings ratio, AFX is valued cheaper than 89.06% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.32. AFX is valued slightly cheaper when compared to this.
- AFX is valuated correctly with a Price/Forward Earnings ratio of 14.45.
- AFX's Price/Forward Earnings ratio is rather cheap when compared to the industry. AFX is cheaper than 81.25% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.57. AFX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.39 | ||
| Fwd PE | 14.45 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AFX is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of AFX indicates a rather cheap valuation: AFX is cheaper than 82.81% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.79 | ||
| EV/EBITDA | 8.62 |
4.3 Compensation for Growth
- AFX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- AFX's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.85
PEG (5Y)5.3
EPS Next 2Y21.07%
EPS Next 3Y21.31%
5. Dividend
5.1 Amount
- AFX has a Yearly Dividend Yield of 1.96%.
- The stock price of AFX dropped by -36.22% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- AFX's Dividend Yield is a higher than the industry average which is at 1.03.
- AFX's Dividend Yield is comparable with the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
5.2 History
- The dividend of AFX decreases each year by -1.59%.
Dividend Growth(5Y)-1.59%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
- AFX pays out 37.19% of its income as dividend. This is a sustainable payout ratio.
DP37.19%
EPS Next 2Y21.07%
EPS Next 3Y21.31%
CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ
What is the fundamental rating for AFX stock?
ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE.
What is the valuation status of CARL ZEISS MEDITEC AG - BR (AFX.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to CARL ZEISS MEDITEC AG - BR (AFX.DE). This can be considered as Undervalued.
Can you provide the profitability details for CARL ZEISS MEDITEC AG - BR?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of CARL ZEISS MEDITEC AG - BR (AFX.DE) stock?
The Price/Earnings (PE) ratio for CARL ZEISS MEDITEC AG - BR (AFX.DE) is 17.39 and the Price/Book (PB) ratio is 1.18.
Is the dividend of CARL ZEISS MEDITEC AG - BR sustainable?
The dividend rating of CARL ZEISS MEDITEC AG - BR (AFX.DE) is 4 / 10 and the dividend payout ratio is 37.19%.